MRP-1与BCRP促进草酸处理的肾上皮细胞磷脂酰丝氨酸外化:对草酸钙尿石症的意义
本研究探讨MRP-1和BCRP在草酸诱导的肾上皮细胞膜磷脂酰丝氨酸(PS)重分布中的作用。体外实验显示草酸浓度依赖性增加MRP-1和BCRP合成,MK571和Ko143可减弱PS外化,N-乙酰半胱氨酸减少其表达;高草酸尿大鼠模型中维拉帕米减轻肾钙质沉着。结论认为草酸通过ROS介导上调MRP-1和BCRP,促进PS外化,参与草酸钙尿石症形成。
要点
- 草酸浓度依赖性增加肾上皮细胞MRP-1和BCRP合成。
- MK571和Ko143分别抑制MRP-1和BCRP,减弱草酸诱导的PS外化。
- 抗氧化剂N-乙酰半胱氨酸减少MRP-1和BCRP表达。
核心结论
- 草酸诱导MRP-1和BCRP上调,二者作为磷脂翻转酶导致肾上皮细胞膜PS外化,该过程由细胞内ROS产生介导,ROS介导的MRP-1和BCRP合成增加可能通过促进PS重分布在髙草酸尿促进的草酸钙尿石症中起重要作用。
研究设计与样本
- 研究采用western blot分析MRP-1和BCRP表达水平,annexin V结合试验检测表面PS,2,7-二氯荧光素二乙酸酯探针测量细胞内ROS。
- 使用0.5%乙二醇和1.0%氯化铵建立高草酸尿大鼠模型,部分动物接受维拉帕米(50 mg/kg体重)处理。
- 采用Pizzolato染色切片组织形态计量学和肾组织草酸钙晶体含量测定评估肾石症程度。
主要发现
- 草酸产生浓度依赖性的MRP-1和BCRP合成增加。
- MK571和Ko143(分别为MRP-1和BCRP特异性抑制剂)处理显著减弱草酸诱导的PS外化。
- 添加抗氧化剂N-乙酰-L-半胱氨酸显著减少MRP-1和BCRP表达。
- 体内实验中,与未接受维拉帕米处理的高草酸尿大鼠模型相比,维拉帕米处理组观察到肾钙质沉着明显减少。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the possible involvement of multidrug resistance-associated protein 1 (MRP-1) and breast cancer resistance protein (BCRP) in the oxalate-induced redistribution of phosphatidylserine (PS) in renal epithelial cell membranes. METHODS: A western blot analysis was used to examine the MRP-1 and BCRP expression levels. Surface-expressed PS was detected by the annexin V-binding assay. The cell-permeable fluorogenic probe 2,7-dichlorofluorescein diacetate was used to measure the intracellular reactive oxygen species (ROS) level. A rat model of hyperoxaluria was obtained using 0.5% ethylene glycol and 1.0% ammonium chloride. In addition, certain animals received verapamil (50 mg/kg body weight), which is a common inhibitor of MRP-1 and BCRP. The degree of nephrolithiasis was assessed histomorphometrically using sections stained by Pizzolato method and by measuring the calcium oxalate crystal content in the renal tissue. RESULTS: Oxalate produced a concentration-dependent increase in the synthesis of MRP-1 and BCRP. Treatment with MK571 and Ko143 (MRP-1- and BCRP-specific inhibitors, respectively) significantly attenuated the oxalate-induced PS externalization. Adding the antioxidant N-acetyl-l-cysteine significantly reduced MRP-1 and BCRP expression. In vivo, markedly decreased nephrocalcinosis was observed compared with that in the rat model of hyperoxaluria without verapamil treatment. CONCLUSION: Oxalate induces the upregulation of MRP-1 and BCRP, which act as phospholipid floppases causing PS externalization in the renal epithelial cell membrane. The process is mediated by intracellular ROS production. The ROS-mediated increase in the synthesis of MRP-1 and BCRP can play an important role in hyperoxaluria-promoted calcium oxalate urolithiasis by facilitating phosphatidylserine redistribution in renal epithelial cells.
引用
- Li Y, Yu S, Gan X, et al. MRP-1 and BCRP Promote the Externalization of Phosphatidylserine in Oxalate-treated Renal Epithelial Cells: Implications for Calcium Oxalate Urolithiasis. Urology. 2017. PMID: 28577929. doi:10.1016/j.urology.2017.05.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。